The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: An analysis of residual risk attributable to lipid profile in acute coronary syndrome.

Jesús Millán Núnez-Cortes; Juan Pedro Botet Montoya; Xavier Pintó Salas; Antonio Hernández Mijares; Vincent J. Carey; Michel P. Hermans; Frank M. Sacks; Jean Charles Fruchart

doi:10.1016/j.endonu.2010.10.004

The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: An analysis of residual risk attributable to lipid profile in acute coronary syndrome.

Jesús Millán Núnez-Cortes, Juan Pedro Botet Montoya, Xavier Pintó Salas, Antonio Hernández Mijares, Vincent J. Carey, Michel P. Hermans, Frank M. Sacks, Jean Charles Fruchart

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

5 Citations (Scopus)

Abstract

The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010. © 2010 SEEN.

Original language	English
Pages (from-to)	38-47
Journal	Endocrinologia y Nutricion
Volume	58
Issue number	1
DOIs	https://doi.org/10.1016/j.endonu.2010.10.004
Publication status	Published - 1 Jan 2011

Keywords

Dyslipidemia
Ischemic heart disease
Residual risk

Access to Document

10.1016/j.endonu.2010.10.004

Fingerprint Dive into the research topics of 'The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: An analysis of residual risk attributable to lipid profile in acute coronary syndrome.'. Together they form a unique fingerprint.

Cite this

Millán Núnez-Cortes, J., Montoya, J. P. B., Salas, X. P., Mijares, A. H., Carey, V. J., Hermans, M. P., Sacks, F. M., & Fruchart, J. C. (2011). The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: An analysis of residual risk attributable to lipid profile in acute coronary syndrome. Endocrinologia y Nutricion, 58(1), 38-47. https://doi.org/10.1016/j.endonu.2010.10.004

Millán Núnez-Cortes, Jesús ; Montoya, Juan Pedro Botet ; Salas, Xavier Pintó ; Mijares, Antonio Hernández ; Carey, Vincent J. ; Hermans, Michel P. ; Sacks, Frank M. ; Fruchart, Jean Charles. / The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: An analysis of residual risk attributable to lipid profile in acute coronary syndrome. In: Endocrinologia y Nutricion. 2011 ; Vol. 58, No. 1. pp. 38-47.

@article{ed4e8225f75947f9865653ae5f768b3f,

title = "The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: An analysis of residual risk attributable to lipid profile in acute coronary syndrome.",

abstract = "The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010. {\textcopyright} 2010 SEEN.",

keywords = "Dyslipidemia, Ischemic heart disease, Residual risk",

author = "{Mill{\'a}n N{\'u}nez-Cortes}, Jes{\'u}s and Montoya, {Juan Pedro Botet} and Salas, {Xavier Pint{\'o}} and Mijares, {Antonio Hern{\'a}ndez} and Carey, {Vincent J.} and Hermans, {Michel P.} and Sacks, {Frank M.} and Fruchart, {Jean Charles}",

year = "2011",

month = jan,

day = "1",

doi = "10.1016/j.endonu.2010.10.004",

language = "English",

volume = "58",

pages = "38--47",

number = "1",

}

Millán Núnez-Cortes, J, Montoya, JPB, Salas, XP, Mijares, AH, Carey, VJ, Hermans, MP, Sacks, FM & Fruchart, JC 2011, 'The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: An analysis of residual risk attributable to lipid profile in acute coronary syndrome.', Endocrinologia y Nutricion, vol. 58, no. 1, pp. 38-47. https://doi.org/10.1016/j.endonu.2010.10.004

The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: An analysis of residual risk attributable to lipid profile in acute coronary syndrome. / Millán Núnez-Cortes, Jesús; Montoya, Juan Pedro Botet; Salas, Xavier Pintó; Mijares, Antonio Hernández; Carey, Vincent J.; Hermans, Michel P.; Sacks, Frank M.; Fruchart, Jean Charles.

In: Endocrinologia y Nutricion, Vol. 58, No. 1, 01.01.2011, p. 38-47.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: An analysis of residual risk attributable to lipid profile in acute coronary syndrome.

AU - Millán Núnez-Cortes, Jesús

AU - Montoya, Juan Pedro Botet

AU - Salas, Xavier Pintó

AU - Mijares, Antonio Hernández

AU - Carey, Vincent J.

AU - Hermans, Michel P.

AU - Sacks, Frank M.

AU - Fruchart, Jean Charles

PY - 2011/1/1

Y1 - 2011/1/1

N2 - The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010. © 2010 SEEN.

AB - The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010. © 2010 SEEN.

KW - Dyslipidemia

KW - Ischemic heart disease

KW - Residual risk

U2 - 10.1016/j.endonu.2010.10.004

DO - 10.1016/j.endonu.2010.10.004

M3 - Article

VL - 58

SP - 38

EP - 47

IS - 1

ER -